Bard Associates’s Pure Cycle PCYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.16M Sell
313,815
-7,443
-2% -$80.7K 0.79% 43
2025
Q4
$3.53M Sell
321,258
-17,113
-5% -$191K 0.91% 39
2025
Q3
$3.75M Sell
338,371
-5,771
-2% -$60.3K 0.99% 43
2025
Q2
$3.69M Sell
344,142
-19,382
-5% -$201K 1.19% 29
2025
Q1
$3.81M Sell
363,524
-6,319
-2% -$71.8K 1.42% 18
2024
Q4
$4.69M Buy
369,843
+4,848
+1% +$59.2K 1.59% 12
2024
Q3
$3.93M Sell
364,995
-5,056
-1% -$51.8K 1.34% 16
2024
Q2
$3.53M Buy
370,051
+855
+0.2% +$8.07K 1.35% 13
2024
Q1
$3.51M Sell
369,196
-1,347
-0.4% -$13.3K 1.26% 18
2023
Q4
$3.88M Sell
370,543
-425
-0.1% -$4.22K 1.47% 12
2023
Q3
$3.56M Buy
370,968
+1,200
+0.3% +$13.5K 1.47% 16
2023
Q2
$4.07M Sell
369,768
-660
-0.2% -$6.55K 1.58% 12
2023
Q1
$3.5M Buy
370,428
+1,600
+0.4% +$14.7K 1.45% 17
2022
Q4
$3.87M Buy
368,828
+11,950
+3% +$112K 1.66% 9
2022
Q3
$2.98M Sell
356,878
-1,380
-0.4% -$14.2K 1.34% 19
2022
Q2
$3.78M Buy
358,258
+5,135
+1% +$55.5K 1.62% 13
2022
Q1
$4.25M Sell
353,123
-600
-0.2% -$7.43K 1.5% 8
2021
Q4
$5.16M Sell
353,723
-1,100
-0.3% -$16.5K 1.7% 6
2021
Q3
$4.72M Buy
354,823
+1,060
+0.3% +$15.3K 1.6% 9
2021
Q2
$4.89M Buy
353,763
+2,035
+0.6% +$29.1K 1.6% 9
2021
Q1
$4.72M Buy
351,728
+6,885
+2% +$83.5K 1.7% 9
2020
Q4
$3.87M Buy
344,843
+2,253
+0.7% +$22.4K 1.53% 12
2020
Q3
$3.09M Sell
342,590
-1,965
-0.6% -$18.5K 1.64% 11
2020
Q2
$3.17M Sell
344,555
-6,700
-2% -$65.5K 1.76% 10
2020
Q1
$3.92M Sell
351,255
-1,950
-0.6% -$23.7K 2.88% 4
2019
Q4
$4.45M Buy
353,205
+10,200
+3% +$120K 2.26% 5
2019
Q3
$3.53M Buy
343,005
+110,575
+48% +$1.18M 1.79% 6
2019
Q2
$2.46M Sell
232,430
-700
-0.3% -$7K 1.23% 22
2019
Q1
$2.3M Sell
233,130
-1,675
-0.7% -$16.6K 1.16% 19
2018
Q4
$2.33M Buy
234,805
+725
+0.3% +$7.36K 1.35% 12
2018
Q3
$2.7M Buy
234,080
+115,630
+98% +$1.26M 1.25% 18
2018
Q2
$1.13M Buy
118,450
+3,250
+3% +$30.8K 0.52% 80
2018
Q1
$1.09M Buy
115,200
+5,800
+5% +$49.8K 0.54% 79
2017
Q4
$913K Buy
109,400
+1,000
+0.9% +$7.52K 0.44% 89
2017
Q3
$813K Hold
108,400
0.38% 97
2017
Q2
$840K Hold
108,400
0.38% 96
2017
Q1
$602K Buy
108,400
+6,800
+7% +$36.1K 0.28% 109
2016
Q4
$559K Buy
101,600
+10,900
+12% +$57.1K 0.26% 104
2016
Q3
$521K Sell
90,700
-800
-0.9% -$3.81K 0.25% 107
2016
Q2
$431K Sell
91,500
-3,100
-3% -$14.1K 0.23% 113
2016
Q1
$427K Hold
94,600
0.25% 112
2015
Q4
$454K Sell
94,600
-7,000
-7% -$34.3K 0.27% 104
2015
Q3
$503K Sell
101,600
-1,900
-2% -$9.34K 0.29% 100
2015
Q2
$538K Sell
103,500
-5,900
-5% -$30.7K 0.27% 101
2015
Q1
$551K Sell
109,400
-1,000
-0.9% -$4.51K 0.26% 108
2014
Q4
$442K Hold
110,400
0.21% 121
2014
Q3
$714K Hold
110,400
0.33% 97
2014
Q2
$747K Sell
110,400
-400
-0.4% -$2.29K 0.3% 115
2014
Q1
$670K Sell
110,800
-1,800
-2% -$11.3K 0.28% 122
2013
Q4
$713K Sell
112,600
-7,550
-6% -$46.5K 0.3% 110
2013
Q3
$555K Sell
120,150
-1,850
-2% -$10K 0.25% 124
2013
Q2
$682K Buy
+122,000
New +$726K 0.32% 109

Other funds holding PCYO

Bard Associates's PCYO Position: Q1 2026 in Review

Bard Associates reduced its Pure Cycle (PCYO) stake by 2.3% in Q1 2026, selling an estimated $80.7K and leaving 313,815 shares worth $3.16M. The position accounts for 0.79% of the portfolio, ranked #43.

Bard Associates first reported a position in PCYO in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.16M in Q4 2021. 116 funds tracked by Wall St. Rank hold PCYO as of Q1 2026.

  • Bard Associates held 313,815 shares of Pure Cycle worth $3.16M as of Q1 2026.
  • Bard Associates sold 7,443 Pure Cycle shares in Q1 2026, an estimated $80.7K.
  • Pure Cycle made up 0.79% of Bard Associates's portfolio in Q1 2026, its #43 holding.
  • Bard Associates first reported a position in Pure Cycle in Q2 2013 and has held it in 52 quarters since.
  • Bard Associates's Pure Cycle position peaked at $5.16M in Q4 2021.
  • 116 funds tracked by Wall St. Rank held Pure Cycle as of Q1 2026.

Based on Bard Associates's 13F filing for Q1 2026, filed 8 May 2026.